| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/20/1999 | WO1999024397A1 Benzocycloheptene derivatives |
| 05/20/1999 | WO1999024044A1 Medicine for promoting cicatrization and containing thrombocytes |
| 05/20/1999 | WO1999024043A1 Viscous compositions containing carbon dioxide |
| 05/20/1999 | WO1999024042A2 Stable antiandrogenic gel composition |
| 05/20/1999 | WO1999024036A1 Skin penetration enhancing components |
| 05/20/1999 | WO1999024035A1 Benzothiazole protein tyrosine kinase inhibitors |
| 05/20/1999 | WO1999024024A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 05/20/1999 | WO1999015653A3 Tie ligand homologues |
| 05/20/1999 | WO1999011666B1 N-terminal modifications of rantes and methods of use |
| 05/20/1999 | WO1999001118A9 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 05/20/1999 | WO1998023574A8 Asiatic acid derivatives and medicines for treating wounds, which contains the same |
| 05/20/1999 | CA2309319A1 Benzothiazole protein tyrosine kinase inhibitors |
| 05/20/1999 | CA2309317A1 Bovine milk growth factor |
| 05/20/1999 | CA2309162A1 Piperidine derivatives and their use as tachykinin antagonists |
| 05/20/1999 | CA2309123A1 Stable antiandrogenic gel composition |
| 05/20/1999 | CA2309007A1 Secreted proteins and polynucleotides encoding them |
| 05/20/1999 | CA2308716A1 Urea derivatives and their use as integrin inhibitors |
| 05/20/1999 | CA2308361A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/20/1999 | CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/20/1999 | CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 05/20/1999 | CA2277379A1 Medicine for promoting cicatrization and containing thrombocytes |
| 05/19/1999 | EP0916729A2 Novel reductase |
| 05/19/1999 | EP0916662A2 Ascorbylsorbate |
| 05/19/1999 | EP0916652A1 N-Aryl 2-hydroxy alkylamides |
| 05/19/1999 | EP0916343A1 use of alkzl phosphoric acid compounds for the treatment of psoriatic diseases |
| 05/19/1999 | EP0916336A1 Transdermal delivery system |
| 05/19/1999 | EP0915974A1 Modified tie-2-receptor ligands |
| 05/19/1999 | EP0915857A1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 05/19/1999 | EP0915843A1 Azetidinone derivatives for the treatment of atheroscleroses |
| 05/19/1999 | EP0915823A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 05/19/1999 | EP0915702A2 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 05/19/1999 | EP0915651A1 Il-8 receptor antagonists |
| 05/19/1999 | EP0756477A4 Methods for phototherapeutic treatment of proliferative skin diseases |
| 05/19/1999 | CN1217028A Method of modulating melanin synthesis |
| 05/19/1999 | CN1217024A Chemokine alpha 2 |
| 05/19/1999 | CN1217022A Therapeutic uses of keratinocyte growth factor |
| 05/19/1999 | CN1216978A New vitamin-D derivatives with carbo- or heterocyclic substitutents at C-25, process for the prodn. intermediate products and their use for producing medicaments |
| 05/19/1999 | CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them |
| 05/19/1999 | CN1043405C Method for prepn. of pharmaceutical compositions contg. heterocyclic amide derivatives |
| 05/18/1999 | US5905265 Method of improving skin condition |
| 05/18/1999 | US5905142 Protease resistant PDGF and methods of use |
| 05/18/1999 | US5905088 Skin disorders, rheumatic diseases, respiratory system or cardiovascular disorders and opthalmological disorders |
| 05/18/1999 | US5905074 Skin disorders, antitumor agents, vitamin d derivatives |
| 05/18/1999 | US5904932 Topical preparation containing a suspension of solid lipid particles |
| 05/14/1999 | WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth |
| 05/14/1999 | WO1999023087A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors |
| 05/14/1999 | WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | WO1999023010A1 Methods and compositions for treating dermatoses |
| 05/14/1999 | WO1999022770A1 Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels |
| 05/14/1999 | WO1999022741A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | WO1999022728A1 Methods and compositions for regulation of 5-alpha reductase activity |
| 05/14/1999 | WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists |
| 05/14/1999 | WO1999004752A3 Methods for treating skin pigmentation |
| 05/14/1999 | WO1998051289A3 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 05/14/1999 | CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | CA2308385A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | CA2307853A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors |
| 05/14/1999 | CA2306866A1 Methods and compositions for treating dermatoses |
| 05/12/1999 | EP0914826A1 Wound healing accelerators |
| 05/12/1999 | EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 05/12/1999 | EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 05/12/1999 | EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 05/12/1999 | EP0914168A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides |
| 05/12/1999 | EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 05/12/1999 | EP0914105A1 Topical medicament comprising phenolic biocide and choline |
| 05/12/1999 | EP0914096A1 Microparticles and their use in wound therapy |
| 05/12/1999 | EP0914094A1 Materials and methods for making improved liposome compositions |
| 05/12/1999 | EP0914089A1 Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions |
| 05/12/1999 | EP0883398A4 Method of inhibiting photoaging of skin |
| 05/12/1999 | EP0772438B1 Use of benzothiophenes for the preparation of a medicament for reducing scarring in wound healing |
| 05/12/1999 | EP0683672B1 Extract from flowers of salvia officinalis, process for its preparation and use thereof |
| 05/12/1999 | CN1216472A A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 05/12/1999 | CN1216250A Chinese medicine for wound |
| 05/11/1999 | US5902824 Phenyldihydrobenzofuranes |
| 05/11/1999 | US5902798 Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate |
| 05/11/1999 | US5902791 Metalloproteinase inhibitors |
| 05/11/1999 | US5902788 For cutaneous melanomas |
| 05/11/1999 | CA2001889C Zinc cysteate, its preparation and uses in pharmacy and cosmetology |
| 05/07/1999 | CA2220621A1 Transdermal delivery system |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999021860A1 Phenanthroline derivatives |
| 05/06/1999 | WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors |
| 05/06/1999 | WO1999021553A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| 05/06/1999 | WO1999021531A1 β-D GLUCAN TOPICAL COMPOSITION |
| 05/06/1999 | WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 05/06/1999 | WO1999007407A9 Heparin-binding growth factor (hbgf) polypeptides |
| 05/06/1999 | EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB) |
| 05/06/1999 | EP0913156A1 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 05/06/1999 | EP0913154A1 Antipsoriatic nail lacquer |
| 05/06/1999 | EP0913150A1 Combination of actives, viz. salicyl alcohol and fumaric acid and/or maleic acid, for the treatment of seborrheoic skin diseases, especially psoriasis |
| 05/06/1999 | EP0912741A2 T-cell selective interleukin-4 agonists |
| 05/06/1999 | EP0912731A2 Secreted proteins |
| 05/06/1999 | EP0912572A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 05/06/1999 | EP0912570A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 05/06/1999 | EP0912568A1 Novel imidazopyridines |
| 05/06/1999 | EP0912559A1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| 05/06/1999 | EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 05/06/1999 | EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 05/06/1999 | EP0912505A1 Il-8 receptor antagonists |